Investment in Women's Health Act of 1998
The source supplies the latest action, but no lifecycle stage.
Latest action (30 Jul 1998): Read twice and referred to the Committee on Finance.
What this bill does
The Investment in Women’s Health Act of 1998, introduced in the Senate, would amend Medicare to ensure that the payment amount for diagnostic or screening Pap smear laboratory tests is no less than $14.60. This change would apply to laboratory tests provided on or after January 1, 1999.
This bill specifically affects individuals covered by Medicare who undergo diagnostic or screening Pap smear laboratory tests. The legislation aims to increase the payment made by Medicare for the laboratory component of these tests.
The bill was introduced in the Senate in July 1998 and referred to the Committee on Finance. As of its introduction, it had not advanced further in the legislative process. For the bill to become law, it would need to be considered and passed by both the Senate and the House of Representatives, and then signed by the President.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Investment in Women's Health Act of 1998 - Amends title XVIII (Medicare) of the Social Security Act to increase to $14.60 the payment for diagnostic or screening pap smear laboratory tests.
Timeline
30 Jul 1998
Read twice and referred to the Committee on Finance.
Common questions
- What does S. 2378 do?
- The Investment in Women’s Health Act of 1998, introduced in the Senate, would amend Medicare to ensure that the payment amount for diagnostic or screening Pap smear laboratory tests is no less than $14.60. This change would apply to laboratory tests provided on or after January 1, 1999. This bill specifically affects individuals covered by Medicare who undergo diagnostic or screening Pap smear laboratory tests. The legislation aims to increase the payment made by Medicare for the laboratory component of these tests. The bill was introduced in the Senate in July 1998 and referred to the Committee on Finance. As of its introduction, it had not advanced further in the legislative process. For the bill to become law, it would need to be considered and passed by both the Senate and the House of Representatives, and then signed by the President.
- Has S. 2378 become law?
- The source does not supply a confirmed lifecycle stage for S. 2378. Check the latest action and official source below.
- Who sponsored S. 2378?
- S. 2378 was sponsored by Sen. Akaka, Daniel K. [D-HI] (D-HI), with 1 cosponsor.
- What's the latest action on S. 2378?
- Read twice and referred to the Committee on Finance. (30 Jul 1998).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Lower Premiums, Faster Payments Act
340B Rebate Model Delay Act
More bills from Sen. Akaka, Daniel K. [D-HI]
Privacy Act Modernization for the Information Age Act of 2011
Identification Security Enhancement Act of 2007
POWER Act of 2007
Identification Security Enhancement Act of 2006
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.